The Norwegian Medicines Verification Company, abbreviated NOMVEC, is a non-profit operating company that is set up by the pharmaceutical industry in Norway to develop and implement an e-verification database for pharmaceutical products in Norway. The objective of EU Directive 2011/62 is to protect prescription-only medicinal products from being falsified. Packaging for such medicinal products will bear new safety features and a unique identifier. Throughout EU a common repositories system will verify prescriptive drugs before it is delivered to a patient. We are setting up the Norwegian verification system. Follow us on twitter @nomvec